Search the Newsreel

Can Tapestry (TPR) Justify Its Valuation Before The August 13 Results Call?

Tempest Therapeutics Adjourns Vote on Governance Changes

Tempest Therapeutics adjourned a special stockholder meeting aimed at approving an amendment to its Restated Certificate of Incorporation to eliminate supermajority voting requirements and allow stockholder action by written consent. Although a quorum was met, the proposal did not secure the required 75% approval. …

Tapestry Inc. stock rises Thursday, still underperforms market

Tapestry Inc. stock rose by 1.65% on Thursday, closing at $152.58. Despite the gain, the stock still underperformed the broader market, as the S&P 500 Index increased by 1.66% and the Dow Jones Industrial Average rose by 1.19%. Tapestry Inc. remains 5.80% below its …

ASP Isotopes to Present at Canaccord Genuity Growth Conference Aug 12

ASP Isotopes (ASPI) will present at Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026. Chief Commercial Officer Viktor Petkov will deliver the company presentation, which will also be available via live audio webcast on the company's investor relations website. The press release …

ASP Isotopes' Aug. 12 presentation will be webcast live

ASP Isotopes (NASDAQ: ASPI) announced that its Chief Commercial Officer, Viktor Petkov, will present at Canaccord Genuity’s 46th Annual Growth Conference on August 12, 2026, at 8:00 a.m. ET. A live webcast and replay of the presentation, focusing on the company's proprietary Aerodynamic Separation …

Tempest Therapeutics Inc (TPST) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Tempest Therapeutics Inc (TPST), detailing its volatility, financial risks, and investment risks. TPST currently has a risk assessment score of 1.53, ranking 288 out of 384 in the Biotechnology & Medical Research industry, with a beta of …

ASP Isotopes to Participate in Canaccord Genuity’s 46th Annual Growth Conference on August 12, 2026

ASP Isotopes Inc. announced that its Chief Commercial Officer, Viktor Petkov, will present at Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026. A live webcast and replay will be available on the company's website. The company is focused on developing isotope enrichment …

Apollo Pipes posts Q1 loss as volatile PVC prices weigh on earnings

Apollo Pipes Q1 Results: Company Swings Into Loss Despite 7% Revenue Uptick

India Pesticides Limited secures fungicide registration in Morocco

Tempest Therapeutics Inc (TPST) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Tempest Therapeutics Inc.'s (TPST) dividend and stock split history. It notes that the company has not distributed any dividends over the past five years. The article also lists several stock merger events with corresponding ratios, including one scheduled …

ASP Isotopes Inc (ASPI) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of ASP Isotopes Inc (ASPI), reporting its current valuation score as 8.28, ranking 98th out of 155 in the Pharmaceuticals industry. The P/E ratio stands at -1.73, which is 34.29% below its recent high and 831.63% above its …

Prince Pipes schedules Q1 FY27 investor call to discuss unaudited results

ASPI|ASP Isotopes Inc|Price:3.535|Chg%:-0.240

This article provides a detailed stock analysis of ASP Isotopes Inc (ASPI) by TradingKey, highlighting its healthy fundamentals, high growth potential, and fair valuation. Despite recent weak market performance, the company shows strong underlying financial health and significant institutional ownership. The analysis also includes …

Tempest Therapeutics Inc (TPST) Financial Health: Profitability & Balance Sheet Analysis

This article provides an analysis of Tempest Therapeutics Inc (TPST)'s financial health, indicating a current score of 6.98, which ranks it 163 out of 384 in the Biotechnology & Medical Research industry. While its financial status is robust, its operating efficiency is low. The …

ASP Isotopes Inc (ASPI) Financial Health: Profitability & Balance Sheet Analysis

ASP Isotopes Inc (ASPI) currently holds a financial score of 7.40, ranking 115 out of 155 in the Pharmaceuticals industry, indicating a stable financial status but low operating efficiency. The company reported a significant year-over-year revenue increase of 279.45% to $4.18 million and a …

TPR|Tapestry Inc|Price:150.170|Chg%:-0.730

Tapestry Inc. (TPR) has a strong fundamental outlook and high growth potential, though its valuation is considered fair within the Specialty Retailers industry. Analysts have largely rated the stock as 'Buy' with a target price of $162.56, suggesting stable performance in the medium term. …

ASP Isotopes Inc (ASPI) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for ASP Isotopes Inc (ASPI), noting its current score of 2.85, ranking 111 out of 155 in the Pharmaceuticals industry. Key metrics include a beta value of 3.41, indicating high volatility relative to the S&P 500, and a …

ASP Isotopes Announces Capital Markets Day in London on September 8, 2026

ASP Isotopes (NASDAQ: ASPI) has announced it will host a Capital Markets Day in London on September 8, 2026, targeting institutional investors, analysts, and media. The event will provide updates on the company's progress and future plans, including its current portfolio and upcoming projects. …

ASP Isotopes to Detail Nuclear Medicine, Fuels at Sept. 8 Event

ASP Isotopes (NASDAQ: ASPI) announced it will host a Capital Markets Day in London on September 8, 2026, where leadership will provide updates on strategy and commercial momentum, with a detailed focus on nuclear medicine, electronic gases, and nuclear fuels. The event will also …

ASP Isotopes to host London Capital Markets Day Sept 8; webcast, strategy update on nuclear medicine, fuels

ASP Isotopes (ASPI) announced a Capital Markets Day in London on September 8, 2026, where leadership will provide updates on strategy and commercial momentum in nuclear medicine, electronic gases, and nuclear fuels. The event will include a presentation and Q&A, with in-person attendance by …

Tapestry Inc (TPR) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Tapestry Inc (TPR), detailing its price momentum, support and resistance levels, and key indicator readings. It shows that TPR's current price momentum score is 2.97, placing it 86th out of 93 in the Specialty Retailers industry, with …

Does Tapestry's (TPR) Earnings Beat Streak Reveal Durable Strength or Cyclical Momentum?

Compagnie des Alpes SA confirme ses objectifs de dividende pour l'exercice 2025/26

Tapestry Inc Lobbyists, 2024

This article details Tapestry Inc.'s lobbying activities and lobbyists for 2024, showing the company spent $70,000 on federal lobbying. It lists 11 named lobbyists, with 9 of them having prior federal government experience, and identifies Ogilvy Government Relations and Sorini, Samet & Assoc as …

Tempest Therapeutics Inc (TPST) Cash Flow

This article provides a comprehensive overview of Tempest Therapeutics Inc.'s (TPST) cash flow statement, including quarterly and annual data for operating, investing, and financing activities. It details specific financial figures, year-over-year changes, and definitions of key cash flow metrics like operating cash flow, investing …

Tapestry Inc (TPR) Stock Up 3.4% but GF Value Says Overvalued -- GF Score: 74/100

Tapestry Inc (TPR) shares rose 3.4% to $147.43, marking a 37.8% increase over the past year. Despite its strong performance and a respectable GF Score™ of 74/100, GuruFocus indicates that TPR is significantly overvalued by 90.7% compared to its GF Value™ of $77.30. Insider …

Arabian Pipes Co. Revenue Breakdown – TADAWUL:2200

ASP Isotopes Inc (ASPI) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides historical dividend and stock split information for ASP Isotopes Inc (ASPI). It notes that no dividends have been distributed over the past five years and contains no dividend data to display. The page also presents current stock price, market cap, and …

Apollo Pipes Q1 Results: Earnings call scheduled for July 31

ASP Isotopes Market Sentiment

This article provides an overview of market sentiment for ASP Isotopes (ASPI), including analyst consensus, short interest, options flow, and insider activity. Key signals indicate a "Buy" consensus from analysts with an average price target of $10, while short interest is rising and insider …

Tapestry, Inc. Revenue Breakdown – LSX:A2JSR1

Tapestry, Inc. generated 5.95 billion EUR last year, with its Coach segment being the top performer, contributing 4.75 billion EUR. The United States market was the largest regional contributor, accounting for 3.57 billion EUR. This data provides a breakdown of the company's revenue by …

ASP Isotopes, Inc. Revenue Breakdown – DUS:W62

The article provides a revenue breakdown for ASP Isotopes, Inc. (DUS:W62), noting that the company generated 20.31 million EUR last year. Its top-performing segment, Construction Services, contributed 15.47 million EUR, with Hong Kong accounting for the entirety of this contribution. The data highlights segments …

Hi-Tech Pipes Ltd. Revenue Breakdown – NSE:HITECH

Tempest Minerals Limited Revenue Breakdown – ASX:TEM

ASP Isotopes Inc (ASPI) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of ASP Isotopes Inc (ASPI), highlighting its current price momentum score of 5.86 within the Pharmaceuticals industry. It details the stock's trading range between a resistance level of $5.84 and a support level of $2.76, making it suitable …